128 results
Page 5 of 7
6-K
njcldpzr8 1sr
9 May 12
Current report (foreign)
12:00am
6-K
EX-99.1
dkht6u ws
8 Mar 12
Teva Receives FDA Approval for ProAirĀ® HFA (albuterol sulfate) with Dose Counter
12:00am
6-K
7gwidws8g7wgh7
2 Nov 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
f4b6nkzw0ajrqefzm
24 Oct 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
xhyw8yjvi6ay7gf
14 Oct 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
kwgd 33dz
21 Sep 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
bv9kx
13 Sep 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
nxxqsfbo my5
8 Aug 11
Teva Receives Fda Acceptance of Its New Drug Application for BDP Nasal Hfa for the Treatment of Allergic Rhinitis
12:00am
6-K
56jly
2 Jun 11
Teva Completes Enrollment In Phase III Multiple Sclerosis Trial Evaluating Glatiramer Acetate Three Times Weekly
12:00am
6-K
fps3g6 0fwhur
9 Feb 11
Teva Announces Results from a Phase III Study for Qnaze??? Nasal Aerosol In Perennial Allergic Rhinitis
12:00am
6-K
hcjl31oi17kuft9 9xnc
19 Oct 10
Early Initiation of Treatment with Copaxone? Provides Greater Effects In Delaying Conversion to Clinically Definite MS
12:00am
6-K
brd87oykr8
19 Oct 10
Early Initiation of Treatment with Copaxone? Provides Greater Effects In Delaying Conversion to Clinically Definite MS
12:00am
6-K
d506gex9
18 Oct 10
New Data Evaluating Laquinimod for the Treatment of Multiple Sclerosis Demonstrate Neuroprotective Effects
12:00am
6-K
hfvlzszdqd9u7c
17 May 10
Teva Announces Tentative Approval of Generic Sensipar?
12:00am
6-K
m4vayq2
17 Mar 09
Study Demonstrates That Qvar? Is More Likely to Achieve Successful Asthma Control with Less Exacerbations
12:00am
6-K
z7q433qhq
24 Sep 08
Teva???s Proair? Hfa, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication - Printer Friendly Version
12:00am